Tear film deficiency producing burning, foreign body sensation, fluctuating vision; aqueous-deficient vs evaporative subtypes drive management.
Also known as: dry eye disease, DED, keratoconjunctivitis sicca, KCS, ocular surface disease
Overview
A multifactorial ocular surface disease characterized by loss of homeostasis of the tear film, accompanied by ocular symptoms in which tear film instability, hyperosmolarity, ocular surface inflammation, and neurosensory abnormalities play etiologic roles (TFOS DEWS II definition).
Epidemiology
Prevalence 5-30% in adults older than 50, varying by definition. Women predominate, with prevalence rising sharply after menopause. Increasingly recognized in younger adults due to screen exposure. Major drivers of healthcare utilization, productivity loss, and reduced quality of life.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Dry Eye Disease (Keratoconjunctivitis Sicca) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Two principal mechanisms, often overlapping: aqueous deficiency (reduced lacrimal gland secretion, as in Sjogren or aging) and evaporative loss (meibomian gland dysfunction, blink abnormalities, lid disease). Resulting tear hyperosmolarity activates inflammatory pathways with release of cytokines (IL-1, TNF-alpha) and matrix metalloproteinases, damaging epithelium, goblet cells, and corneal nerves. This perpetuates a vicious cycle of inflammation and instability.
Clinical presentation
Symptoms
Burning, grittiness, foreign body sensation
Stinging, intermittent sharp pain
Reflex tearing — paradoxical excessive tearing from a hyperosmolar surface
Fluctuating or blurred vision that improves with blinking
Difficulty with prolonged reading, screen use, driving (reduced blink rate)
Photophobia in severe disease
Contact lens intolerance
Worsening throughout the day or with low-humidity environments
Signs / physical exam
Decreased tear meniscus height (normal >0.2 mm)
Reduced tear breakup time (TBUT) — less than 10 seconds is abnormal; less than 5 seconds is significant
Schirmer test less than 10 mm/5 min suggestive; less than 5 mm/5 min indicates aqueous deficiency
Corneal and conjunctival staining with fluorescein, lissamine green, or rose bengal — interpalpebral pattern in aqueous deficiency, inferior in evaporative
Meibomian gland dysfunction — capped or atrophic glands, thick or absent expression
Lid margin telangiectasia, posterior lid margin keratinization
Filaments in severe disease
Classic findings
Middle-aged or older patient with fluctuating vision, burning, reduced tear breakup time, and inferior or interpalpebral corneal staining.
Differential diagnosis
Allergic conjunctivitis — Itching is dominant; bilateral, papillary conjunctivitis, eyelid edema, atopic history
Blepharitis / meibomian gland dysfunction — Lid margin erythema, telangiectasia, capped meibomian orifices, collarettes; overlaps with evaporative dry eye
TFOS DEWS II: positive symptom score (DEQ-5 or OSDI) PLUS at least one of: tear osmolarity ≥308 mOsm/L or interocular difference >8 mOsm/L; tear breakup time <10 s; ocular surface staining (>5 corneal spots, >9 conjunctival spots, or lid margin staining ≥2 mm length and ≥25% width).
Labs
Tear film osmolarity (TearLab) — elevated and asymmetric values support diagnosis
MMP-9 point-of-care testing (InflammaDry) — positive when ocular surface inflammation is significant
Sjogren panel if dry mouth, parotid swelling, or systemic symptoms: anti-Ro/SS-A, anti-La/SS-B, ANA, RF, ESR, CRP
Salivary gland biopsy (minor) by rheumatology when Sjogren suspected
Imaging
Slit-lamp examination with fluorescein, lissamine green, and meibography
Schirmer test (with and without anesthesia)
Tear breakup time (noninvasive preferred)
Meibography (infrared imaging of meibomian glands) to quantify gland dropout
Confocal microscopy of cornea for nerve and inflammatory cell density (specialized)
Diagnostic algorithm
Severity
Symptoms
Signs
Treatment
Level 1 (mild, episodic)
Mild, environmental
Mild conjunctival staining; TBUT borderline
Education, environmental modification, artificial tears prn, lid hygiene
Tarsorrhaphy, amniotic membrane, systemic immunosuppression for autoimmune cause, surgical consultation
Stepwise management of dry eye disease (adapted from TFOS DEWS II).
Treatment
First-line
Patient education: blink hygiene during screen use (20-20-20 rule), humidification, avoidance of fans and direct air, eyelid hygiene for MGD
Artificial tears — preservative-free if used more than 4 times per day; formulations with lipid components (e.g., systane complete, refresh optive advanced) for evaporative disease
Warm compresses with lid massage and expression for meibomian gland dysfunction
Treat underlying ocular surface contributors — discontinue offending topical preservatives, address allergic eye disease, treat blepharitis with lid hygiene and topical/oral antibiotics if indicated (azithromycin, doxycycline)
Second-line / adjunct
Topical anti-inflammatory therapy — cyclosporine 0.05% (Restasis), cyclosporine 0.09% (Cequa), lifitegrast 5% (Xiidra), or perfluorohexyloctane (Miebo) for evaporative
Short course of topical corticosteroid (loteprednol etabonate, fluorometholone) — useful for acute flares; monitor IOP
Punctal plugs (collagen temporary, silicone permanent) for aqueous deficient disease
Oral secretagogues (pilocarpine, cevimeline) in Sjogren syndrome
Autologous serum tears for severe disease
Scleral contact lenses for advanced or chronic disease
Intense pulsed light (IPL) and thermal pulsation (LipiFlow) for meibomian gland dysfunction
Tarsorrhaphy for severe persistent epithelial defects or exposure keratopathy
Complications
Filamentary keratitis
Persistent corneal epithelial defects and corneal ulceration
Corneal scarring or perforation in severe disease
Recurrent corneal erosion
Reduced visual acuity and contrast sensitivity
Contact lens intolerance
Reduced quality of life with depression and anxiety
PANCE pearls
Symptoms often correlate poorly with exam — believe the patient even when staining is mild.
Determine whether the disease is aqueous deficient, evaporative, or mixed — this dictates therapy.
Reflex tearing is a hallmark of dry eye, not its opposite.
Always evaluate the lid margins and meibomian glands; untreated MGD undermines other therapies.
Consider Sjogren syndrome in any woman with dry eye plus dry mouth, parotid swelling, or arthralgia.
Avoid chronic topical decongestants — they worsen dry eye and cause rebound hyperemia.
References
TFOS DEWS II — Tear Film and Ocular Surface Society Dry Eye Workshop II (Craig et al., Ocul Surf 2017)
AAO PPP — American Academy of Ophthalmology Preferred Practice Pattern: Dry Eye Syndrome
AAO BCSC — American Academy of Ophthalmology Basic and Clinical Science Course: External Disease and Cornea
Practice EENT questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.